The small MAF transcription factors MAFF, MAFG and MAFK: Current knowledge and perspectives

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1841-1846

  Kannan, Meenakshi B ^a,b   Solovieva, Vera ^a,b   Blank, Volker ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

BZIP; Cancer; CNC; Gene regulation; MAF; Stress signaling

Indexed keywords

TRANSCRIPTION FACTOR MAFF; TRANSCRIPTION FACTOR MAFG; TRANSCRIPTION FACTOR MAFK;

CARCINOGENESIS; DIABETES MELLITUS; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTOPENIA;

ANIMALS; DISEASE; GENE REGULATORY NETWORKS; HUMANS; MAF TRANSCRIPTION FACTORS, SMALL; METABOLIC DETOXICATION, DRUG; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL;

MAMMALIA;

EID: 84864770285     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.012     Document Type: Review

References (81)

1. Nishizawa M., Kataoka K., Goto N., Fujiwara K.T., Kawai S. v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:7711-7715.
2. Vinson C., Acharya A., Taparowsky E.J. Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim. Biophys. Acta 2006, 1759:4-12.
3. Yang Y., Cvekl A. Large Maf transcription factors: cousins of AP-1 proteins and important regulators of cellular differentiation. Einstein J. Biol. Med. 2007, 23:2-11.
4. Kataoka K. Multiple mechanisms and functions of maf transcription factors in the regulation of tissue-specific genes. J. Biochem. 2007, 141:775-781.
5. Eychene A., Rocques N., Pouponnot C. A new MAFia in cancer. Nat. Rev. Cancer 2008, 8:683-693.
6. Blank V., Knoll J.H., Andrews N.C. Molecular characterization and localization of the human MAFG gene. Genomics 1997, 44:147-149.
7. Motohashi H., Katsuoka F., Engel J.D., Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6379-6384.
8. Francastel C., Magis W., Groudine M. Nuclear relocation of a transactivator subunit precedes target gene activation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12120-12125.
9. Brand M., Ranish J.A., Kummer N.T., Hamilton J., Igarashi K., Francastel C., Chi T.C., Crabtree G.R., Aebersold R., Groudine M. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Nat. Struct. Mol. Biol. 2004, 11:73-80.
10. Massrieh W., Derjuga A., Doualla-Bell F., Ku C.Y., Sanborn B.M., Blank V. Regulation of the MAFF transcription factor by proinflammatory cytokines in myometrial cells. Biol. Reprod. 2006, 74:699-705.
11. Onodera K., Shavit J.A., Motohashi H., Katsuoka F., Akasaka J., Engel J.D., Yamamoto M. Characterization of the murine mafF gene [In Process Citation]. J. Biol. Chem. 1999, 274:21162-21169.
12. Murphy P., Kolsto A. Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development. Mech. Dev. 2000, 97:141-148.
13. Lecoin L., Sii-Felice K., Pouponnot C., Eychene A., Felder-Schmittbuhl M.P. Comparison of maf gene expression patterns during chick embryo development. Gene Expr. Patterns 2004, 4:35-46.
14. Bai Q., Assou S., Haouzi D., Ramirez J.M., Monzo C., Becker F., Gerbal-Chaloin S., Hamamah S., De Vos J. Dissecting the first transcriptional divergence during human embryonic development. Stem Cell Rev. 2011, 8:150-162.
15. Toki T., Itoh J., Kitazawa J., Arai K., Hatakeyama K., Akasaka J., Igarashi K., Nomura N., Yokoyama M., Yamamoto M., Ito E. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene 1997, 14:1901-1910.
16. Shimokawa N., Okada J., Miura M. Cloning of MafG homologue from the rat brain by differential display and its expression after hypercapnic stimulation. Mol. Cell. Biochem. 2000, 203:135-141.
17. Shimokawa N., Kumaki I., Takayama K. MafG-2 is a novel Maf protein that is expressed by stimulation of extracellular H(+). Cell. Signal. 2001, 13:835-839.
18. Kumaki I., Yang D., Koibuchi N., Takayama K. Neuronal expression of nuclear transcription factor MafG in the rat medulla oblongata after baroreceptor stimulation. Life Sci. 2006, 78:1760-1766.
19. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J. Mol. Biol. 2008, 376:913-925.
20. Motohashi H., O'Connor T., Katsuoka F., Engel J., Yamamoto M. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 2002, 294:1-12.
21. Blank V., Andrews N.C. The Maf transcription factors: regulators of differentiation. Trends Biochem. Sci. 1997, 22:437-441.
22. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., Engel J.D. The world according to Maf. Nucleic Acids Res. 1997, 25:2953-2959.
23. Igarashi K., Kataoka K., Itoh K., Hayashi N., Nishizawa M., Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins [see comments]. Nature 1994, 367:568-572.
24. Kerppola T.K., Curran T. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene 1994, 9:675-684.
25. Kurokawa H., Motohashi H., Sueno S., Kimura M., Takagawa H., Kanno Y., Yamamoto M., Tanaka T. Structural basis of alternative DNA recognition by Maf transcription factors. Mol. Cell. Biol. 2009, 29:6232-6244.
26. Igarashi K., Itoh K., Motohashi H., Hayashi N., Matuzaki Y., Nakauchi H., Nishizawa M., Yamamoto M. Activity and expression of murine small Maf family protein MafK. J. Biol. Chem. 1995, 270:7615-7624.
27. Motohashi H., Katsuoka F., Shavit J.A., Engel J.D., Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 2000, 103:865-875.
28. Li W., Yu S., Liu T., Kim J.H., Blank V., Li H., Kong A.N. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim. Biophys. Acta 2008, 1783:1847-1856.
29. Ueda K., Xu J., Morimoto H., Kawabe A., Imaoka S. MafG controls the hypoxic response of cells by accumulating HIF-1alpha in the nuclei. FEBS Lett. 2008, 582:2357-2364.
30. Chen L., Fink T., Ebbesen P., Zachar V. Temporal transcriptome of mouse ATDC5 chondroprogenitors differentiating under hypoxic conditions. Exp. Cell Res. 2006, 312:1727-1744.
31. Igarashi K., Sun J. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid. Redox Signal. 2006, 8:107-118.
32. Katoh Y., Ikura T., Hoshikawa Y., Tashiro S., Ito T., Ohta M., Kera Y., Noda T., Igarashi K. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol. Cell 2011, 41:554-566.
33. Yang H., Li T.W., Peng J., Mato J.M., Lu S.C. Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells. Biochem. J. 2011, 436:507-516.
34. Woo A.J., Kim J., Xu J., Huang H., Cantor A.B. Role of ZBP-89 in human globin gene regulation and erythroid differentiation. Blood 2011, 118:3684-3693.
35. Morin P., Ni Z., McMullen D.C., Storey K.B. Expression of Nrf2 and its downstream gene targets in hibernating 13-lined ground squirrels, Spermophilus tridecemlineatus. Mol. Cell. Biochem. 2008, 312:121-129.
36. Ni Z., Storey K.B. Heme oxygenase expression and Nrf2 signaling during hibernation in ground squirrels. Can. J. Physiol. Pharmacol. 2010, 88:379-387.
37. Hung H.L., Kim A.Y., Hong W., Rakowski C., Blobel G.A. Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J. Biol. Chem. 2001, 276:10715-10721.
38. Liu G.H., Qu J., Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim. Biophys. Acta 2008, 1783:713-727.
39. Motohashi H., Katsuoka F., Miyoshi C., Uchimura Y., Saitoh H., Francastel C., Engel J.D., Yamamoto M. MafG sumoylation is required for active transcriptional repression. Mol. Cell. Biol. 2006, 26:4652-4663.
40. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
41. Katsuoka F., Motohashi H., Ishii T., Aburatani H., Engel J.D., Yamamoto M. Genetic evidence that small Maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 2005, 25:8044-8051.
42. Yamazaki H., Katsuoka F., Motohashi H., Engel J.D., Yamamoto M. Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. Mol. Cell. Biol. 2011, 32:808-816.
43. Kataoka K., Han S.I., Shioda S., Hirai M., Nishizawa M., Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J. Biol. Chem. 2002, 277:49903-49910.
44. Olbrot M., Rud J., Moss L.G., Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6737-6742.
45. Kajihara M., Sone H., Amemiya M., Katoh Y., Isogai M., Shimano H., Yamada N., Takahashi S. Mouse MafA, homologue of zebrafish somite Maf 1, contributes to the specific transcriptional activity through the insulin promoter. Biochem. Biophys. Res. Commun. 2003, 312:831-842.
46. Matsuoka T.A., Artner I., Henderson E., Means A., Sander M., Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2930-2933.
47. Zhang C., Moriguchi T., Kajihara M., Esaki R., Harada A., Shimohata H., Oishi H., Hamada M., Morito N., Hasegawa K., Kudo T., Engel J.D., Yamamoto M., Takahashi S. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 2005, 25:4969-4976.
48. Shimohata H., Yoh K., Fujita A., Morito N., Ojima M., Tanaka H., Hirayama K., Kobayashi M., Kudo T., Yamagata K., Takahashi S. MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy. Biochem. Biophys. Res. Commun. 2009, 389:235-240.
49. Menegazzo L., Albiero M., Avogaro A., Fadini G.P. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012, 38:194-202.
50. van Oostrom O., de Kleijn D.P., Fledderus J.O., Pescatori M., Stubbs A., Tuinenburg A., Lim S.K., Verhaar M.C. Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study. Cardiovasc. Diabetol. 2009, 8:47.
51. Torocsik B., Angelastro J.M., Greene L.A. The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth. J. Neurosci. 2002, 22:8971-8980.
52. Ro Y.T., Jang B.K., Shin C.Y., Park E.U., Kim C.G., Yang S.I. Akt regulates the expression of MafK, synaptotagmin I, and syntenin-1, which play roles in neuronal function. J. Biomed. Sci. 2010, 17:18.
53. Katsuoka F., Motohashi H., Tamagawa Y., Kure S., Igarashi K., Engel J.D., Yamamoto M. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol. Cell. Biol. 2003, 23:1163-1174.
54. Dijkmans T.F., van Hooijdonk L.W., Schouten T.G., Kamphorst J.T., Fitzsimons C.P., Vreugdenhil E. Identification of new Nerve Growth Factor-responsive immediate-early genes. Brain Res. 2009, 1249:19-33.
55. Amit I., Citri A., Shay T., Lu Y., Katz M., Zhang F., Tarcic G., Siwak D., Lahad J., Jacob-Hirsch J., Amariglio N., Vaisman N., Segal E., Rechavi G., Alon U., Mills G.B., Domany E., Yarden Y. A module of negative feedback regulators defines growth factor signaling. Nat. Genet. 2007, 39:503-512.
56. Cook A.L., Vitale A.M., Ravishankar S., Matigian N., Sutherland G.T., Shan J., Sutharsan R., Perry C., Silburn P.A., Mellick G.D., Whitelaw M.L., Wells C.A., Mackay-Sim A., Wood S.A. NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease. PLoS One 2011, 6:e21907.
57. Shavit J.A., Motohashi H., Onodera K., Akasaka J., Yamamoto M., Engel J.D. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 1998, 12:2164-2174.
58. Moussa O., LaRue A.C., Abangan R.S., Williams C.R., Zhang X.K., Masuya M., Gong Y.Z., Spyropoulos D.D., Ogawa M., Gilkeson G., Watson D.K. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol. Cell. Biol. 2010, 30:5194-5206.
59. Motohashi H., Fujita R., Takayama M., Inoue A., Katsuoka F., Bresnick E.H., Yamamoto M. Molecular determinants for small Maf protein control of platelet production. Mol. Cell. Biol. 2011, 31:151-162.
60. Li X.M., Hu Z., Zafar A.B., Jorgensen M.L., Bungert J., Slayton W. Intrinsic and extrinsic effects of mafG deficiency on hematopoietic recovery following bone marrow transplant. Exp. Hematol. 2010, 38:1251-1260.
61. Yamane A., Nakamura T., Suzuki H., Ito M., Ohnishi Y., Ikeda Y., Miyakawa Y. Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 2008, 112:542-550.
62. Motohashi H., Yamamoto M. Carcinogenesis and transcriptional regulation through Maf recognition elements. Cancer Sci. 2007, 98:135-139.
63. Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 2010, 13:1713-1748.
64. Wang X., Chorley B.N., Pittman G.S., Kleeberger S.R., Brothers J., Liu G., Spira A., Bell D.A. Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One 2010, 5:e11934.
65. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., Lu J., Liu G., Bowers J., Vaziri C., Ott K., Sensinger K., Collins J.J., Brody J.S., Getts R., Lenburg M.E., Spira A. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2319-2324.
66. Reinmuth N., Fan F., Liu W., Parikh A.A., Stoeltzing O., Jung Y.D., Bucana C.D., Radinsky R., Gallick G.E., Ellis L.M. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab. Invest. 2002, 82:1377-1389.
67. Balkhi M.Y., Trivedi A.K., Geletu M., Christopeit M., Bohlander S.K., Behre H.M., Behre G. Proteomics of acute myeloid leukaemia: cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene 2006, 25:7041-7058.
68. Lopez-Perez R., Gutierrez N.C., Isidro I.M., Maiso P., Gonzales M., Hernandez J.M. Absence of differences in the gene expression profiling of a childhood ALL. Blood 2003, 102.
69. Kataoka K., Igarashi K., Itoh K., Fujiwara K.T., Noda M., Yamamoto M., Nishizawa M. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor [published erratum appears in Mol Cell Biol 1995 Jun;15(6):3461]. Mol. Cell. Biol. 1995, 15:2180-2190.
70. Marini M.G., Asunis I., Chan K., Chan J.Y., Kan Y.W., Porcu L., Cao A., Moi P. Cloning MafF by recognition site screening with the NF-E2 tandem repeat of HS2: analysis of its role in globin and GCSI genes regulation. Blood Cells Mol. Dis. 2002, 29:145-148.
71. Johnsen O., Skammelsrud N., Luna L., Nishizawa M., Prydz H., Kolsto A.B. Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1. Nucleic Acids Res. 1996, 24:4289-4297.
72. Marini M.G., Chan K., Casula L., Kan Y.W., Cao A., Moi P. hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J. Biol. Chem. 1997, 272:16490-16497.
73. Itoh K., Igarashi K., Hayashi N., Nishizawa M., Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell. Biol. 1995, 15:4184-4193.
74. Massrieh W., Derjuga A., Blank V. Induction of endogenous Nrf2/small maf heterodimers by arsenic-mediated stress in placental choriocarcinoma cells. Antioxid. Redox Signal. 2006, 8:53-59.
75. Kobayashi A., Ito E., Toki T., Kogame K., Takahashi S., Igarashi K., Hayashi N., Yamamoto M. Molecular cloning and functional characterization of a new Cap 'n' Collar family transcription factor Nrf3. J. Biol. Chem. 1999, 274:6443-6452.
76. Chenais B., Derjuga A., Massrieh W., Red-Horse K., Bellingard V., Fisher S.J., Blank V. Functional and placental expression analysis of the human NRF3 transcription factor. Mol. Endocrinol. 2005, 19:125-137.
77. Oyake T., Itoh K., Motohashi H., Hayashi N., Hoshino H., Nishizawa M., Yamamoto M., Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 1996, 16:6083-6095.
78. Shimokawa N., Kumaki I., Qiu C.H., Ohmiya Y., Takayama K., Koibuchi N. Extracellular acidification enhances DNA binding activity of MafG-FosB heterodimer. J. Cell. Physiol. 2005, 205:77-85.
79. Ye X., Li Y., Huang Q., Yu Y., Yuan H., Wang P., Wan D., Gu J., Huo K., Li Y.Y., Lu H. The novel human gene MIP functions as a co-activator of hMafF. Arch. Biochem. Biophys. 2006, 449:87-93.
80. Kataoka K., Fujiwara K.T., Noda M., Nishizawa M. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol. Cell. Biol. 1994, 14:7581-7591.
81. Kataoka K., Yoshitomo-Nakagawa K., Shioda S., Nishizawa M. A set of Hox proteins interact with the Maf oncoprotein to inhibit its DNA binding, transactivation, and transforming activities. J. Biol. Chem. 2001, 276:819-826.